VEGFR / Flt Antibodies

Santa Cruz Biotechnology features a diverse variety of VEGFR / Flt monoclonal antibodies for research in vascular biology and angiogenesis. VEGFR / Flt Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vascular Endothelial Growth Factor Receptor (VEGFR), also known as Flt, mediates the effects of VEGF, which is essential for blood vessel formation and maintenance. VEGFR function is crucial for normal physiological processes and plays a significant role in pathological conditions such as cancer, where abnormal angiogenesis can lead to tumor growth and metastasis. Research focused on VEGFR signaling pathways continues to reveal potential therapeutic targets for various diseases. Scientists worldwide utilize VEGFR / Flt monoclonal antibodies to advance understanding of angiogenesis mechanisms. Exploring VEGFR's role in different biological processes helps identify new treatment strategies for vascular disorders. VEGFR / Flt monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to vascular biology research and therapeutic development.